logo

For the Inventor, By the Inventor

Choisy le Roi, France

Odile Piot-Grosjean

This inventor holds 4 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2006-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Odile Piot-Grosjean. Retrieved from https://idiyas.com/inventor/odile-piot-grosjean

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal4 out of 377 
 
Aventis Pharma S.a.
 patents

Years Active: 2006-2007

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7217705 - Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease (2007-05-15),
2. 7148258 - Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity (2006-12-12),
3. 7105504 - Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease (2006-09-12),
4. 7037944 - Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity (2006-05-02),

Title: Odile Piot-Grosjean: Innovator in Pharmaceutical Research

Introduction

Odile Piot-Grosjean is a notable inventor based in Choisy le Roi, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological and metabolic disorders. With a total of four patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Odile's latest patents include innovative combinations aimed at addressing critical health issues. One of her notable inventions is a combination of a CB1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain. This pharmaceutical composition is designed for the treatment of Parkinson's disease. Another significant patent involves the combination of a CB1 receptor antagonist and sibutramine, which is aimed at treating obesity. These inventions highlight her commitment to advancing medical treatments through innovative research.

Career Highlights

Throughout her career, Odile has been associated with Aventis Pharma S.A., where she has contributed to various research projects. Her expertise in pharmacology and her innovative approach have positioned her as a key figure in her field.

Collaborations

Odile has collaborated with esteemed colleagues such as Jésus Benavides and Daniel Boccio. These partnerships have further enriched her research and development efforts, leading to impactful advancements in pharmaceutical science.

Conclusion

Odile Piot-Grosjean's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to the treatment of Parkinson's disease and obesity through her patented inventions are a testament to her dedication and expertise. She continues to inspire future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…